Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- A4340 PimobendanTarget: Phosphodiesterases (PDEs)Summary: Selective PDE3 inhibitor.Ca2+ channel sensitizer
- A4342 GimeracilSummary: Dihydropyrimidine dehydrogenase inhibitor
- A4343 DyphyllineSummary: Pan-PDE inhibitor
- A4344 OzagrelSummary: Thromboxane A2 synthetase inhibitor
- A4345 MK-8245Summary: SCD inhibitor,potent and liver-selective
- A4346 AminophyllineTarget: Phosphodiesterases (PDEs)Summary: Pan-PDE inhibitor
- A4347 Methotrexate4 CitationTarget: Folate AnalogueSummary: Folate antagonist,inhibits DFHR
- A4348 TrilostaneSummary: 3β-HSD inhibitor
- A4349 S- (+)-RolipramSummary: CAMP-specific PDE4 inhibitor
- A4350 PralatrexateSummary: Antifolate,a folate analog